A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Clinical trial NCT01505530 · COMPLETED

Trial details

NCT number: NCT01505530
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2011-12-01
Primary completion: 2014-10-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.